Tonghua Dongbao Pharmaceutical Co.,ltd
Clinical trials sponsored by Tonghua Dongbao Pharmaceutical Co.,ltd, explained in plain language.
-
New insulin contender tested in 550 chinese patients with type 1 diabetes
Disease control CompletedThis study tested a new insulin called THDB0206 against a standard insulin (lispro) in 550 Chinese adults with type 1 diabetes. Both groups also used a long-acting insulin (glargine). The main goal was to see how well the new insulin controls blood sugar over 26 weeks. Participan…
Phase: PHASE3 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
New insulin candidate shows promise in large diabetes trial
Disease control CompletedThis study tested a new insulin called THDB0206 against a commonly used insulin (lispro) in over 1000 Chinese adults with type 2 diabetes. Both insulins were taken alongside a long-acting insulin (glargine). The goal was to see how well each controlled blood sugar over 26 weeks. …
Phase: PHASE3 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated May 26, 2026 05:28 UTC
-
Where you inject insulin matters: new study tests different spots
Knowledge-focused CompletedThis study looked at how a new insulin (THDB0206) works when injected into different body areas. 27 healthy Chinese adults received a single dose in three different spots on separate days. Researchers measured how fast the insulin was absorbed and how it affected blood sugar. The…
Phase: PHASE1 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC